Efficient enzymatic cyclization of an inhibitory cystine knot-containing peptide

Biotechnology and Bioengineering

Volumn 113, Issue 10, 2016, Pages 2202-2212

  Kwon, Soohyun ^a   Bosmans, Frank ^b   Kaas, Quentin ^a   Cheneval, Olivier ^a   Conibear, Anne C ^a   Rosengren, K Johan ^a   Wang, Conan K ^a   Schroeder, Christina I ^a   Craik, David J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cyclization; inhibitory cystine knot; sortase A; PVIIA

Indexed keywords

CONFORMATIONS; COVALENT BONDS; CYSTINES; HYDROGEN BONDS; PEPTIDES;

BACKBONE CYCLIZATION; CONFORMATIONAL DYNAMICS; FUNCTIONAL PEPTIDES; HYDROGEN BOND NETWORKS; INHIBITORY CYSTINE KNOT; PROTEIN ENGINEERING; SORTASE A; THERAPEUTIC MOLECULES;

CYCLIZATION;

ARTICLE; CYCLIZATION;

EID: 84983731362     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25993     Document Type: Article

References (77)

1. Akcan M, Clark RJ, Daly NL, Conibear AC, de Faoite A, Heghinian MD, Sahil T, Adams DJ, Mari F, Craik DJ. 2015. Transforming conotoxins into cyclotides: Backbone cyclization of P-superfamily conotoxins. Biopolymers 104:682–692.
2. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. 2001. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc Natl Acad Sci USA 98:10037–10041.
3. Barton ME, White HS, Wilcox KS. 2004. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs. Epilepsy Res 59:13–24.
4. Blanco-Canosa JB, Nardone B, Albericio F, Dawson PE. 2015. Chemical protein synthesis using a second-generation N-acylurea linker for the preparation of peptide-thioester precursors. J Am Chem Soc 137:7197–7209.
5. Boccaccio A, Conti F, Olivera BM, Terlau H. 2004. Binding of kappa-conotoxin PVIIA to Shaker K+ channels reveals different K+ and Rb+ occupancies within the ion channel pore. J Gen Physiol 124:71–81.
6. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54:905–921.
7. Burgess DL, Kohrman DC, Galt J, Plummer NW, Jones JM, Spear B, Meisler MH. 1995. Mutation of a new sodium channel gene, Scn8a, in the mouse mutant ‘motor endplate disease’. Nat Genet 10:461–465.
8. Bussi G, Donadio D, Parrinello M. 2007. Canonical sampling through velocity rescaling. J Chem Phys 126:014101.
9. Chan LY, Gunasekera S, Henriques ST, Worth NF, Le SJ, Clark RJ, Campbell JH, Craik DJ, Daly NL. 2011. Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds. Blood 118:6709–6717.
10. Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. 2010. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12–21.
11. Chen I, Dorr BM, Liu DR. 2011. A general strategy for the evolution of bond-forming enzymes using yeast display. Proc Natl Acad Sci USA 108:11399–11404.
12. Cheneval O, Schroeder CI, Durek T, Walsh P, Huang YH, Liras S, Price DA, Craik DJ. 2014. Fmoc-based synthesis of disulfide-rich cyclic peptides. J Org Chem 79:5538–5544.
13. Clark RJ, Jensen J, Nevin ST, Callaghan BP, Adams DJ, Craik DJ. 2010. The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew Chem Int Ed Engl 49:6545–6548.
14. Colgrave ML, Craik DJ. 2004. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: The importance of the cyclic cystine knot. Biochemistry 43:5965–5975.
15. Conibear AC, Rosengren KJ, Harvey PJ, Craik DJ. 2012. Structural characterization of the cyclic cystine ladder motif of theta-defensins. Biochemistry 51:9718–9726.
16. Craik DJ, Conibear AC. 2011. The chemistry of cyclotides. J Org Chem 76:4805–4817.
17. Craik DJ, Daly NL, Waine C. 2001. The cystine knot motif in toxins and implications for drug design. Toxicon 39:43–60.
18. Cushman DW, Ondetti MA. 1999. Design of angiotensin converting enzyme inhibitors. Nat Med 5:1110–1113.
19. Daly NL, Craik DJ. 2011. Bioactive cystine knot proteins. Curr Opin Chem Biol 15:362–368.
20. Daly NL, Love S, Alewood PF, Craik DJ. 1999. Chemical synthesis and folding pathways of large cyclic polypeptide: Studies of the cystine knot polypeptide kalata B1. Biochemistry 38:10606–10614.
21. Daly NL, Ekberg JA, Thomas L, Adams DJ, Lewis RJ, Craik DJ. 2004. Structures of muO-conotoxins from Conus marmoreus. Inhibitors of tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels in mammalian sensory neurons. J Biol Chem 279:25774–25782.
22. Dawson PE, Muir TW, Clark-Lewis I, Kent SB. 1994. Synthesis of proteins by native chemical ligation. Science 266:776–779.
23. Fainzilber M, van der Schors R, Lodder JC, Li KW, Geraerts WP, Kits KS. 1995. New sodium channel-blocking conotoxins also affect calcium currents in Lymnaea neurons. Biochemistry 34:5364–5371.
24. Fosgerau K, Hoffmann T. 2015. Peptide therapeutics: Current status and future directions. Drug Discov Today 20:122–128.
25. Frech GC, VanDongen AM, Schuster G, Brown AM, Joho RH. 1989. A novel potassium channel with delayed rectifier properties isolated from rat brain by expression cloning. Nature 340:642–645.
26. Garcia ML, Garcia-Calvo M, Hidalgo P, Lee A, MacKinnon R. 1994. Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom. Biochemistry 33:6834–6839.
27. Gilchrist J, Das S, Van Petegem F, Bosmans F. 2013. Crystallographic insights into sodium-channel modulation by the beta4 subunit. Proc Natl Acad Sci USA 110:E5016–E5024.
28. Gran L. 1970. An oxytocic principle found in Oldenlandia affinis DC. Medd Nor Farm Selsk 12:173–180.
29. Grupe A, Schroter KH, Ruppersberg JP, Stocker M, Drewes T, Beckh S, Pongs O. 1990. Cloning and expression of a human voltage-gated potassium channel. A novel member of the RCK potassium channel family. EMBO J 9:1749–1756.
30. Guntert P. 2004. Automated NMR structure calculation with CYANA. Methods Mol Biol 278:353–378.
31. Heinemann SH, Leipold E. 2007. Conotoxins of the O-superfamily affecting voltage-gated sodium channels. Cell Mol Life Sci 64:1329–1340.
32. Heinz TN, van Gunsteren WF, Hunenberger PH. 2001. Comparison of four methods to compute the dielectric permittivity of liquids from molecular dynamics simulations. J Chem Phys 115:1125–1136.
33. Hemu X, Taichi M, Qiu Y, Liu DX, Tam JP. 2013. Biomimetic synthesis of cyclic peptides using novel thioester surrogates. Biopolymers 100:492–501.
34. Hill JM, Alewood PF, Craik DJ. 1997. Solution structure of the sodium channel antagonist conotoxin GS: A new molecular caliper for probing sodium channel geometry. Structure 5:571–583.
35. Hoshi T, Zagotta WN, Aldrich RW. 1990. Biophysical and molecular mechanisms of Shaker potassium channel inactivation. Science 250:533–538.
36. Huang X, Dong F, Zhou HX. 2005. Electrostatic recognition and induced fit in the kappa-PVIIA toxin binding to Shaker potassium channel. J Am Chem Soc 127:6836–6849.
37. Ireland DC, Colgrave ML, Craik DJ. 2006. A novel suite of cyclotides from Viola odorata: Sequence variation and the implications for structure, function and stability. Biochem J 400:1–12.
38. Jacobsen RB, Koch ED, Lange-Malecki B, Stocker M, Verhey J, Van Wagoner RM, Vyazovkina A, Olivera BM, Terlau H. 2000. Single amino acid substitutions in kappa-conotoxin PVIIA disrupt interaction with the shaker K+ channel. J Biol Chem 275:24639–24644.
39. Jia X, Kwon S, Wang CI, Huang YH, Chan LY, Tan CC, Rosengren KJ, Mulvenna JP, Schroeder CI, Craik DJ. 2014. Semienzymatic cyclization of disulfide-rich peptides using Sortase A. J Biol Chem 289:6627–6638.
40. Kaas Q, Westermann JC, Craik DJ. 2010. Conopeptide characterization and classifications: An analysis using ConoServer. Toxicon 55:1491–1509.
41. Kaas Q, Yu R, Jin AH, Dutertre S, Craik DJ. 2012. ConoServer: Updated content, knowledge, and discovery tools in the conopeptide database. Nucleic Acids Res 40:D325–D330.
42. Kalia J, Milescu M, Salvatierra J, Wagner J, Klint JK, King GF, Olivera BM, Bosmans F. 2015. From foe to friend: Using animal toxins to investigate ion channel function. J Mol Biol 427:158–175.
43. Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, Shah K, Mulvany K, Hora D, Jr., Cunningham P, Wunderler DL, McManus OB, Slaughter R, Bugianesi R, Felix J, Garcia M, Williamson J, Kaczorowski G, Sigal NH, Springer MS, Feeney W. 1997. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol 158:5120–5128.
44. Koradi R, Billeter M, Wuthrich K. 1996. MOLMOL: A program for display and analysis of macromolecular structures. J Mol Graph 14:51–55.
45. Li-Smerin Y, Swartz KJ. 1998. Gating modifier toxins reveal a conserved structural motif in voltage-gated Ca2+ and K+ channels. Proc Natl Acad Sci USA 95:8585–8589.
46. Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, Shaw DE. 2010. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78:1950–1958.
47. Lu Z, Klem AM, Ramu Y. 2001. Ion conduction pore is conserved among potassium channels. Nature 413:809–813.
48. Mahdavi S, Kuyucak S. 2013. Why the Drosophila Shaker K+ channel is not a good model for ligand binding to voltage-gated Kv1 channels. Biochemistry 52:1631–1640.
49. Miljanich GP. 2004. Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain. Curr Med Chem 11:3029–3040.
50. Nielsen KJ, Thomas L, Lewis RJ, Alewood PF, Craik DJ. 1996. A consensus structure for omega-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: Comparison of MVIIA SVIB and SNX-202. J Mol Biol 263:297–310.
51. Nielsen DS, Lohman RJ, Hoang HN, Hill TA, Jones A, Lucke AJ, Fairlie DP. 2015. Flexibility versus rigidity for orally bioavailable cyclic hexapeptides. Chembiochem 16:2289–2293.
52. Norton RS, Pallaghy PK. 1998. The cystine knot structure of ion channel toxins and related polypeptides. Toxicon 36:1573–1583.
53. Pallaghy PK, Nielsen KJ, Craik DJ, Norton RS. 1994. A common structural motif incorporating a cystine knot and a triple-stranded beta-sheet in toxic and inhibitory polypeptides. Protein Sci 3:1833–1839.
54. Parrinello M, Rahman A. 1981. Polymorphic transitions in single-crystals—A new molecular-dynamics method. J Appl Phys 52:7182–7190.
55. Popp MW, Ploegh HL. 2011. Making and breaking peptide bonds: Protein engineering using sortase. Angew Chem Int Ed Engl 50:5024–5032.
56. Popp MW, Antos JM, Ploegh HL. 2009. Site-specific protein labeling via sortase-mediated transpeptidation. Curr Protoc Protein Sci 56:15.3.1–15.3.9.
57. Pronk S, Pall S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, van der Spoel D, Hess B, Lindahl E. 2013. GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29:845–854.
58. Rangaraju S, Chi V, Pennington MW, Chandy KG. 2009. Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opin Ther Targets 13:909–924.
59. Sali A, Blundell TL. 1993. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779–815.
60. Savarin P, Guenneugues M, Gilquin B, Lamthanh H, Gasparini S, Zinn-Justin S, Menez A. 1998. Three-dimensional structure of kappa-conotoxin PVIIA, a novel potassium channel-blocking toxin from cone snails. Biochemistry 37:5407–5416.
61. Scanlon MJ, Naranjo D, Thomas L, Alewood PF, Lewis RJ, Craik DJ. 1997. Solution structure and proposed binding mechanism of a novel potassium channel toxin kappa-conotoxin PVIIA. Structure 5:1585–1597.
62. Schaller KL, Krzemien DM, Yarowsky PJ, Krueger BK, Caldwell JH. 1995. A novel, abundant sodium channel expressed in neurons and glia. J Neurosci 15:3231–3242.
63. Schmid N, Eichenberger AP, Choutko A, Riniker S, Winger M, Mark AE, van Gunsteren WF. 2011. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur Biophys J 40:843–856.
64. Shon KJ, Grilley MM, Marsh M, Yoshikami D, Hall AR, Kurz B, Gray WR, Imperial JS, Hillyard DR, Olivera BM. 1995. Purification, characterization, synthesis, and cloning of the lockjaw peptide from Conus purpurascens venom. Biochemistry 34:4913–4918.
65. Shon KJ, Stocker M, Terlau H, Stuhmer W, Jacobsen R, Walker C, Grilley M, Watkins M, Hillyard DR, Gray WR, Olivera BM. 1998. Kappa-Conotoxin PVIIA is a peptide inhibiting the shaker K+ channel. J Biol Chem 273:33–38.
66. Stanger K, Maurer T, Kaluarachchi H, Coons M, Franke Y, Hannoush RN. 2014. Backbone cyclization of a recombinant cystine-knot peptide by engineered Sortase A. FEBS Lett 588:4487–4496.
67. Stuhmer W, Ruppersberg JP, Schroter KH, Sakmann B, Stocker M, Giese KP, Perschke A, Baumann A, Pongs O. 1989. Molecular basis of functional diversity of voltage-gated potassium channels in mammalian brain. EMBO J 8:3235–3244.
68. Swanson R, Marshall J, Smith JS, Williams JB, Boyle MB, Folander K, Luneau CJ, Antanavage J, Oliva C, Buhrow SA, Bennet C, Stein RB, Kaczmarek LK. 1990. Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain. Neuron 4:929–939.
69. Tam JP, Lu YA, Yang JL, Chiu KW. 1999. An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Proc Natl Acad Sci USA 96:8913–8918.
70. Tempel BL, Papazian DM, Schwarz TL, Jan YN, Jan LY. 1987. Sequence of a probable potassium channel component encoded at Shaker locus of Drosophila. Science 237:770–775.
71. Terlau H, Shon KJ, Grilley M, Stocker M, Stuhmer W, Olivera BM. 1996. Strategy for rapid immobilization of prey by a fish-hunting marine snail. Nature 381:148–151.
72. Ton-That H, Liu G, Mazmanian SK, Faull KF, Schneewind O. 1999. Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif. Proc Natl Acad Sci USA 96:12424–12429.
73. Trimmer JS, Cooperman SS, Tomiko SA, Zhou JY, Crean SM, Boyle MB, Kallen RG, Sheng ZH, Barchi RL, Sigworth FJ, Goodman RH, Agnew WS, Mandel G. 1989. Primary structure and functional expression of a mammalian skeletal muscle sodium channel. Neuron 3:33–49.
74. Wüthrich K. 1986. NMR of proteins and nucleic acids. New York: Wiley-Interscience.
75. Wang CK, Northfield SE, Colless B, Chaousis S, Hamernig I, Lohman RJ, Nielsen DS, Schroeder CI, Liras S, Price DA, Fairlie DP, Craik DJ. 2014. Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficients. Proc Natl Acad Sci USA 111:17504–17509.
76. Witte MD, Cragnolini JJ, Dougan SK, Yoder NC, Popp MW, Ploegh HL. 2012. Preparation of unnatural N-to-N and C-to-C protein fusions. Proc Natl Acad Sci USA 109:11993–11998.
77. Zhu SY, Darbon H, Dyason K, Verdonck F, Tytgat J. 2003. Evolutionary origin of inhibitor cystine knot peptides. FASEB J 17:1765–1767.